Our results suggested that SELENBP1 deficiency regulates DC maturation homeostasis and DC-mediated Treg balance, which could potentially be used in the treatment of sepsis, autoimmune diseases, and allergic diseases; however, more research is necessary to elucidate the optimal route of administration, time, concentration, and frequency of DC administration [60,72]. This evidence concerns the gene SELENBP1 and Sepsis.